ATE103808T1 - N-(3,4-dimethoxycinnamoyl)-anthranilsaeure enthaltende arzneimittelzusammensetzungen. - Google Patents

N-(3,4-dimethoxycinnamoyl)-anthranilsaeure enthaltende arzneimittelzusammensetzungen.

Info

Publication number
ATE103808T1
ATE103808T1 AT89311879T AT89311879T ATE103808T1 AT E103808 T1 ATE103808 T1 AT E103808T1 AT 89311879 T AT89311879 T AT 89311879T AT 89311879 T AT89311879 T AT 89311879T AT E103808 T1 ATE103808 T1 AT E103808T1
Authority
AT
Austria
Prior art keywords
dimethoxycinnamoyl
anthranilic acid
composition
compositions containing
medicinal compositions
Prior art date
Application number
AT89311879T
Other languages
English (en)
Inventor
Tokihiko - Aza Kannok Yamamoto
Taihei Shibazaki
Yukiyoshi Ajisawa
Ryoji Yamamoto
Yukuhiko Kinoshita
Original Assignee
Kissei Pharmaceutical
Nitten Ophthalmic Research Ins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13861211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE103808(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kissei Pharmaceutical, Nitten Ophthalmic Research Ins filed Critical Kissei Pharmaceutical
Application granted granted Critical
Publication of ATE103808T1 publication Critical patent/ATE103808T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT89311879T 1989-04-04 1989-11-16 N-(3,4-dimethoxycinnamoyl)-anthranilsaeure enthaltende arzneimittelzusammensetzungen. ATE103808T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1085521A JPH07116029B2 (ja) 1989-04-04 1989-04-04 トラニラスト水溶液製剤
EP89311879A EP0391002B1 (de) 1989-04-04 1989-11-16 N-(3,4-dimethoxycinnamoyl)-Anthranilsäure enthaltende Arzneimittelzusammensetzungen

Publications (1)

Publication Number Publication Date
ATE103808T1 true ATE103808T1 (de) 1994-04-15

Family

ID=13861211

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89311879T ATE103808T1 (de) 1989-04-04 1989-11-16 N-(3,4-dimethoxycinnamoyl)-anthranilsaeure enthaltende arzneimittelzusammensetzungen.

Country Status (12)

Country Link
US (1) US5356620A (de)
EP (1) EP0391002B1 (de)
JP (1) JPH07116029B2 (de)
KR (1) KR940002660B1 (de)
AT (1) ATE103808T1 (de)
AU (1) AU623191B2 (de)
CA (1) CA2003190C (de)
DE (1) DE68914438T2 (de)
DK (1) DK555089A (de)
ES (1) ES2063146T3 (de)
FI (1) FI95773C (de)
NO (1) NO176346C (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897858A (en) 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
US6239177B1 (en) * 1996-02-07 2001-05-29 Lead Chemical Co., Ltd. Tranilast-containing preparation for external application and method of producing the same
JPH09278653A (ja) * 1996-04-05 1997-10-28 Santen Pharmaceut Co Ltd 網膜疾患治療剤
IL118657A0 (en) * 1996-06-14 1996-10-16 Arad Dorit Inhibitors for picornavirus proteases
DE69720521T2 (de) * 1996-09-28 2004-03-04 Kissei Pharmaceutical Co., Ltd., Matsumoto Hemmer der subepithelialen turbidität
BR9712308A (pt) * 1996-10-14 1999-08-31 Kissie Pharmaceutical Co Ltd Inibidor de catarata secundária
IL131216A (en) * 1997-02-14 2003-10-31 Kissei Pharmaceutical Drugs inhibiting progress of pterygium and postoperative recurrence of the same
NZ500300A (en) * 1997-04-18 2001-01-26 Kissei Pharmaceutical Compositions containing N-(3,4-dimethoxycinnamoyl) anthranilic acid for the treatment of excessive proliferation of retinal pigment epithelial cells
IL122591A0 (en) 1997-12-14 1998-06-15 Arad Dorit Pharmaceutical compositions comprising cystein protease inhibitors
US6274626B1 (en) 1998-12-22 2001-08-14 Bausch & Lomb Incorporated Pheniramine-containing compositions and method for treating allergic responses
JP2001158750A (ja) * 1999-12-02 2001-06-12 Lion Corp 眼科用組成物及び抗アレルギー薬の持続性向上方法
JP4541504B2 (ja) * 2000-06-14 2010-09-08 沢井製薬株式会社 トラニラストまたはその薬理学的に許容される塩を有効成分として含有する安定な水溶液製剤
AU2002234236A1 (en) * 2001-01-10 2002-07-24 Smithkline Beecham Corporation Process and product
JP2011225626A (ja) * 2001-02-01 2011-11-10 Rohto Pharmaceutical Co Ltd 点眼剤
JP2002363075A (ja) * 2001-06-05 2002-12-18 Kao Corp 高血圧症予防・治療剤
DE10254872A1 (de) 2002-11-25 2004-06-03 Symrise Gmbh & Co. Kg Anthranilsäureamide und deren Derivate als kosmetische und pharmazeutische Wirkstoffe
JP2004189731A (ja) * 2002-11-26 2004-07-08 Taisho Pharmaceut Co Ltd 点鼻剤
US20050106230A1 (en) * 2003-11-17 2005-05-19 Young Janel E. Drug-enhanced adhesion prevention
JP2006306765A (ja) * 2005-04-27 2006-11-09 Nippon Tenganyaku Kenkyusho:Kk トラニラスト水性点眼液
KR101704953B1 (ko) * 2006-07-05 2017-02-08 피브로테크 세라퓨틱 피티와이 엘티디 치료 화합물
KR20160017139A (ko) * 2007-12-21 2016-02-15 피브로테크 세라퓨틱 피티와이 엘티디 항섬유증 제제의 할로겐화 유사체
US9062076B2 (en) 2009-10-22 2015-06-23 Fibrotech Therapeutics Pty Ltd Fused ring analogues of anti-fibrotic agents
MX2013000578A (es) * 2010-07-21 2013-02-21 Alcon Res Ltd Composicion farmaceutica con caracteristicas de solubilidad incrementadas.
JP7191515B2 (ja) * 2017-01-17 2022-12-19 ロート製薬株式会社 眼科組成物
SG11201907139UA (en) 2017-02-03 2019-09-27 Certa Therapeutics Pty Ltd Anti-fibrotic compounds
JP6427244B2 (ja) * 2017-10-03 2018-11-21 ロート製薬株式会社 点眼剤
TWI651095B (zh) * 2017-10-18 2019-02-21 晶碩光學股份有限公司 具有抗敏舒緩效果的眼用產品
CN109718376B (zh) * 2017-10-27 2022-01-25 晶硕光学股份有限公司 具有抗敏舒缓效果的眼用产品
EP3837238B1 (de) * 2018-08-14 2024-06-12 Nuformix Technologies Limited Kristalline tranilastsalze und ihre pharmazeutische verwendung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1296518A (fr) * 1959-04-25 1962-06-22 Véhicule liquide pour collyre
US3856919A (en) * 1970-06-08 1974-12-24 Burton Parsons Chemicals Inc Ophthalmic solution
US4070484A (en) * 1973-01-18 1978-01-24 Kissei Pharmaceutical Co., Ltd. Antiallergic composition containing aromatic carboxylic amide derivatives and method of using the same
US4029817A (en) * 1973-09-24 1977-06-14 Allergan Pharmaceuticals Soft contact lens preserving solutions
JPS6144811A (ja) * 1984-08-10 1986-03-04 Ss Pharmaceut Co Ltd 徐放性ジクロフエナクナトリウム製剤
US4666929A (en) * 1985-04-10 1987-05-19 Shiseido Company Ltd. Anthranilic acid ester derivatives and antiinflammatory and analgetic external preparations containing the same
CA1291036C (en) * 1986-04-23 1991-10-22 Edwin I. Stoltz Nasal administration of drugs
WO1988004922A1 (fr) * 1986-12-25 1988-07-14 Teysan Pharmaceuticals Co., Ltd. Granule a dissolution lente et granule composite a effet persistant prepare a partir du premier granule

Also Published As

Publication number Publication date
JPH07116029B2 (ja) 1995-12-13
DK555089A (da) 1990-10-05
DE68914438D1 (de) 1994-05-11
EP0391002B1 (de) 1994-04-06
DK555089D0 (da) 1989-11-07
NO176346C (no) 1995-03-22
FI95773B (fi) 1995-12-15
CA2003190C (en) 1997-04-29
KR900015722A (ko) 1990-11-10
NO894602L (no) 1990-10-05
JPH02264716A (ja) 1990-10-29
FI895492A0 (fi) 1989-11-17
NO176346B (no) 1994-12-12
AU4438489A (en) 1990-10-11
NO894602D0 (no) 1989-11-17
EP0391002A3 (de) 1991-06-26
HK1003780A1 (en) 1998-11-06
KR940002660B1 (ko) 1994-03-28
CA2003190A1 (en) 1990-10-04
DE68914438T2 (de) 1994-07-28
ES2063146T3 (es) 1995-01-01
US5356620A (en) 1994-10-18
EP0391002A2 (de) 1990-10-10
AU623191B2 (en) 1992-05-07
FI95773C (fi) 1996-03-25

Similar Documents

Publication Publication Date Title
ATE103808T1 (de) N-(3,4-dimethoxycinnamoyl)-anthranilsaeure enthaltende arzneimittelzusammensetzungen.
FI901421A0 (fi) N-(3-hydroxi-4-piperidinyl) (dihydrobenzofuran, dihydro-2h-benzopyran- eller dihydrobenzodioxin) karboxiamidderivat.
MA22014A1 (fr) Derives d'acides amines .
DE69008366D1 (de) 2-Aminopyrimidinon-Derivate.
BR0213242A (pt) Composto ou um seu sal ou solvato, composto e seus sais de adição de ácido fisiologicamente aceitáveis, composição farmacêutica, método de tratamento de um ou mais distúrbios, uso de um composto, e, processo de preparação de um composto
PH25504A (en) Novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides pharmaceutical composition containing said compound, method of use thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee